Ls Investment Advisors, LLC Enanta Pharmaceuticals Inc Transaction History

Ls Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $71,587 - $88,378	-1,651 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$57.95 - $66.61 $65,077 - $74,803	1,123 Added 212.69%	1,651 $102,000
Q4 2018 Feb 01, 2019	SELL	$65.41 - $84.65 $160,777 - $208,069	-2,458 Reduced 82.32%	528 $37,000
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $57,941 - $85,678	-678 Reduced 18.5%	2,986 $255,000
Q2 2018 Jul 20, 2018	BUY	$81.85 - $120.51 $2,782 - $4,097	34 Added 0.94%	3,664 $425,000
Q1 2018 May 08, 2018	SELL	$57.91 - $92.15 $4,864 - $7,740	-84 Reduced 2.26%	3,630 $294,000
Q4 2017 Feb 07, 2018	BUY	$45.65 - $59.37 $61,399 - $79,852	1,345 Added 56.78%	3,714 $218,000
Q3 2017 Oct 19, 2017	BUY	$37.91 - $46.8 $89,808 - $110,869	2,369	2,369 $111,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $183M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.